Cite
Yan D, Franzini A, Pomicter AD, et al. SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA. Blood Cancer Discov. 2019;2(3):266-287doi: 10.1158/2643-3230.BCD-20-0168.
Yan, D., Franzini, A., Pomicter, A. D., Halverson, B. J., Antelope, O., Mason, C. C., Ahmann, J. M., Senina, A. V., Vellore, N. A., Jones, C. L., Zabriskie, M. S., Than, H., Xiao, M. J., van Scoyk, A., Patel, A. B., Clair, P. M., Heaton, W. L., Owen, S. C., Andersen, J. L., Egbert, C. M., Reisz, J. A., D'Alessandro, A., Cox, J. E., Gantz, K. C., Redwine, H. M., Iyer, S. M., Khorashad, J. S., Rajabi, N., Olsen, C. A., O'Hare, T., & Deininger, M. W. (2021). SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA. Blood cancer discovery, 2(3), 266-287. https://doi.org/10.1158/2643-3230.BCD-20-0168
Yan, Dongqing, et al. "SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA." Blood cancer discovery vol. 2,3 (2021): 266-287. doi: https://doi.org/10.1158/2643-3230.BCD-20-0168
Yan D, Franzini A, Pomicter AD, Halverson BJ, Antelope O, Mason CC, Ahmann JM, Senina AV, Vellore NA, Jones CL, Zabriskie MS, Than H, Xiao MJ, van Scoyk A, Patel AB, Clair PM, Heaton WL, Owen SC, Andersen JL, Egbert CM, Reisz JA, D'Alessandro A, Cox JE, Gantz KC, Redwine HM, Iyer SM, Khorashad JS, Rajabi N, Olsen CA, O'Hare T, Deininger MW. SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA. Blood Cancer Discov. 2021 May;2(3):266-287. doi: 10.1158/2643-3230.BCD-20-0168. Epub 2019 Dec 02. PMID: 34027418; PMCID: PMC8133360.
Copy
Download .nbib